Currently, two mechanisms are considered responsible for TKIs resistance in CML: BCR::ABL1-dependent resistance, involving mutations or overexpression of BCR::ABL1, and BCR::ABL1-independent resistance, which does not depend on BCR::ABL1. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.